Bivarus raises $4M Series B round to enhance data visualization and analytics for products
Bivarus plans to use some of the funding to add 10-15 new employees around the Research Triangle over the next year.
5 takeaways from Bioventus IPO move
Bioventus develops orthopedic products designed to treat conditions affecting muscles, bones and joints. Its top sellers include a therapy for fractures and osteoarthritis,
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
5 interesting things from Quintiles IPO filing
The rumors, it seems were true after all. In an environment where initial public offerings by life science companies have all but dried up, Quintiles, the largest contract research organization, has filed documents with the Securities and Exchange Commission seeking to raise up to $600 million in an IPO. This is Quintiles’ second IPO. Its […]